Pancreatic Cancer Research

ResearcherStanford MedicineActive in the last 2 years

Pejman Ghanouni

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6393-0964; OpenAlex author ID A5000304926. Sources: ClinicalTrials.gov.

Their work

Papers
1 (first author 0, last author 1)
Trials
2 (principal investigator on 2)
Grants
0
Labs led
0
Collaborators
3
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: 1 trial · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 trial

Papers 1

  1. A meta-analysis of palliative treatment of pancreatic cancer with high intensity focused ultrasound. Last author DOI 10.1186/s40349-017-0080-4↗

Trials 2

  1. Feasibility Study of Suizenji, in Patients With Unresectable Pancreatic Ductal Adenocarcinoma (SUNRISE-II) Principal investigator NCT07033689↗
  2. Magnetic Resonance Guided High Intensity Focused Ultrasound in Advanced Pancreatic Adenocarcinoma Treatment Principal investigator NCT04298242↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Alessandro Napoli · 1 shared paper, 2017 · strength 0.07
  2. Susan Dababou · 1 shared paper, 2017 · strength 0.07
  3. Joo Ha Hwang · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.